As for the IPITT results, the AUC showed a decreasing trend but did not reach statistical significance in TG-treated Lv-shPKACα mice when compared with untreated Lv-shPKACα mice (Fig. 7 E).
← all excerpts
Tectorigenin targets PKACα to promote GLUT4 expression in skeletal muscle and improve insulin resistance <i>in vitro</i> and <i>in vivo</i>.
1
—
—